GÜVEN, B. Et Al. 2022. Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect. ECCR 2022 , (Treviso, Italy).

GÜVEN, B., QIUYU, S., PERSAD, K. L., WAGG, C., OLIVEIRA, A. A., SILVER, H., ... ANDRE, D. J.(2022). Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect . ECCR 2022, Treviso, Italy

GÜVEN, BERNA Et Al. "Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect," ECCR 2022, Treviso, Italy, 2022

GÜVEN, BERNA G. Et Al. "Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect." ECCR 2022 , Treviso, Italy, 2022

GÜVEN, B. Et Al. (2022) . "Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect." ECCR 2022 , Treviso, Italy.

@conferencepaper{conferencepaper, author={BERNA GÜVEN ÇİLOĞLU Et Al. }, title={Metabolic Effects of Carvedilol on Control and HFpEF Mouse Heart and Hypertrophied H9c2 Cells: The Potential Contribution of a Biased Agonist Effect}, congress name={ECCR 2022}, city={Treviso}, country={Italy}, year={2022}}